Keywords: Pfizer, Lyrica, Partial onset seizures, Epilepsy, Ph III

Pfizer's Lyrica equals levetiracetam in patients with partial onset seizures

Article | 22 February 2013

Print This

Global pharma behemoth Pfizer (NYSE: PFE) has announced top-line results from a Phase III study showing its neuropathic pain drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in